You have 9 free searches left this month | for more free features.

BH4

Showing 1 - 25 of 2,762

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

BH4 Blood Levels Variations in Pre Eclamptic Women

Recruiting
  • Pre Eclampsia
  • +4 more
  • BH4 blood level
  • Tunis, Tunisia
    Tunis maternity and neonatology center, minisetry of public heal
Apr 26, 2023

Phenylketonuria Trial in Galveston (tetrahydrobiopterin (BH4))

Terminated
  • Phenylketonuria
  • tetrahydrobiopterin (BH4)
  • Galveston, Texas
    University of Texas Medical Branch
Sep 20, 2021

Renal Insufficiency, Chronic Trial in Atlanta, Decatur (drug, other, dietary supplement)

Recruiting
  • Renal Insufficiency, Chronic
  • Atlanta, Georgia
  • +2 more
Jan 20, 2022

Endothelial Dysfunction Trial in Hackensack (Sapropterin DiHCl, Sapropterin DiHCl and Vitamin C)

Completed
  • Endothelial Dysfunction
  • Sapropterin Dihydrochloride
  • Sapropterin Dihydrochloride and Vitamin C
  • Hackensack, New Jersey
    (unnamed)
Apr 22, 2021

Radiation Enteritis Trial in Chengdu (Tetrahydrobiopterin)

Recruiting
  • Radiation Enteritis
  • Chengdu, Sichuan, China
    est China Second Hospital of Sichuan University
Feb 25, 2022

BH4 Deficiency, Hyperphenylalaninemia Trial in United States (CNSA-001)

Completed
  • BH4 Deficiency
  • Hyperphenylalaninemia
  • Minneapolis, Minnesota
  • +3 more
Nov 9, 2021

Phenylketonuria Trial in Cleveland (saproterin diHCl, Diet treatment)

Completed
  • Phenylketonuria
  • saproterin dihydrochloride
  • Diet treatment
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Apr 26, 2022

Heart Failure With Reduced Ejection Fraction Trial in Salt Lake City (Antioxidant, Tetrahydrobiopterin (BH4), Exercise training)

Recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Antioxidant
  • +2 more
  • Salt Lake City, Utah
    VA Salt Lake City Health Care System, Salt Lake City, UT
Jun 17, 2022

Head and Neck Squamous Cell Carcinoma Trial (Sapropterin diHCl tablets)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Sapropterin dihydrochloride tablets
  • (no location specified)
Mar 17, 2022

COPD, Pulmonary Artery Hypertension, Heart Failure Trial in Salt Lake City (Maximum Exercise Tests, BH4, L-NMMA, Vitamin C,

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • +3 more
  • Maximum Exercise Tests
  • +6 more
  • Salt Lake City, Utah
    George E Wahlen VA Medical Center
Sep 15, 2021

Peripheral Artery Disease, Peripheral Arterial Disease Trial (Sapropterin DiHCl (BH4, tetrahydrobiopterin), Placebo)

Withdrawn
  • Peripheral Artery Disease
  • Peripheral Arterial Disease
  • Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin)
  • Placebo
  • (no location specified)
Nov 24, 2020

Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA

Not yet recruiting
  • Cerebral Infarction
  • +2 more
  • Dipeptidyl peptidase-4 inhibitor
  • (no location specified)
Apr 5, 2023

Deep Vein Thrombosis Trial in Poole (geko™ post-surgery for 48hrs then 4hrs/day until discharge., TEDS post-surgery for 48hrs

Completed
  • Deep Vein Thrombosis
  • geko™ post-surgery for 48hrs then 4hrs/day until discharge.
  • TEDS post-surgery for 48hrs then 4hrs/day until discharge.
  • Poole, Dorset, United Kingdom
    BMI The Harbour Hospital
Aug 4, 2022

Sickle Cell Disease Trial in United States (Sapropterin DiHCl)

Completed
  • Sickle Cell Disease
  • Sapropterin Dihydrochloride
  • Washington, District of Columbia
  • +11 more
Feb 3, 2021

Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency Trial in Worldwide

Completed
  • Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency
    • Graz, Austria
    • +68 more
    Apr 14, 2022

    Rheumatologic Disease Trial in Salt Lake City (BH4, Vasculopathy assessment, Placebo)

    Completed
    • Rheumatologic Disease
    • BH4
    • +2 more
    • Salt Lake City, Utah
      VA Salt Lake City Health Care System, Salt Lake City, UT
    Apr 1, 2021

    Tetrahydrobiopterin Deficiencies, Hyperphenylalaninemia, Non-Phenylketonuric Trial in Germany, United States (Phenoptin)

    Completed
    • Tetrahydrobiopterin Deficiencies
    • Hyperphenylalaninemia, Non-Phenylketonuric
    • Los Angeles, California
    • +9 more
    Sep 24, 2020

    HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

    Recruiting
    • HER2-negative Breast Cancer
    • Batumi, Georgia
    • +18 more
    Jan 13, 2023

    COPD (COPD) Trial in Augusta (Tetrahydrobiopterin (BH4), Antioxidant Cocktail)

    Completed
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Tetrahydrobiopterin (BH4)
    • Antioxidant Cocktail
    • Augusta, Georgia
      Georgia Prevention Institute
    Feb 5, 2021

    Phenylketonuria Trial in Canada, United States (sapropterin diHCl)

    Completed
    • Phenylketonuria
    • sapropterin dihydrochloride
    • La Jolla, California
    • +18 more
    Dec 1, 2020

    Venous Leg Ulcer, Leg Ulcers Venous, Leg Ulcer Trial in United Kingdom (geko™ medical device)

    Active, not recruiting
    • Venous Leg Ulcer
    • +4 more
    • geko™ medical device
    • Southsea, Portsmouth, United Kingdom
    • +22 more
    Aug 4, 2022

    Coronary Artery Disease Trial in Worldwide (CT-guided PCI, IVUS-guided PCI)

    Recruiting
    • Coronary Artery Disease
    • CT-guided PCI
    • IVUS-guided PCI
    • Jette, Brussels, Belgium
    • +13 more
    May 30, 2022

    Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)

    Active, not recruiting
    • Secondary Progressive Multiple Sclerosis (SPMS)
    • Belfast, United Kingdom
    • +23 more
    Jul 4, 2022

    Malignant Biliary Obstruction Trial in Bournemouth, Manchester (Intraductal Radio-Frequency Ablation, Biliary Stent Placement)

    Not yet recruiting
    • Malignant Biliary Obstruction
    • Intraductal Radio-Frequency Ablation
    • Biliary Stent Placement
    • Bournemouth, Dorset, United Kingdom
    • +1 more
    May 16, 2022

    Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Kraków, Poland
    • +10 more
    Dec 2, 2022